Cardiovascular diagnostics tools
Ultromics has raised €87M across 3 funding rounds from 18 investors, most recently a Series C round in Jul 2025. Based in Oxford, UK; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2025-07-31 | Series C | €48M | Allegis Capital,Blue Venture Fund,GV,L&G Capital,Lightrock,Oxford Science Enterprises+3 more | View deal → |
| 2021-08-16 | Series B | €28M | Blue Venture Fund,GV,Optum Ventures,Oxford Sciences Innovation | View deal → |
| 2018-02-01 | Series A | €11M | Andre Crawford-Brunt,Dieter Spälti.,Fushia,GT Healthcare,Neptune,Oxford Sciences Innovation+2 more | View deal → |
